Recent MS-HAN Alerts
-
Region IV Special Pathogens Training Course – April 5, 2023 – Jackson, MS
MSHAN-20230309-00592-ALT
-
Emergency Addition of Syphilis Infection During Pregnancy as a Reportable Disease and Requirement of Syphilis Testing During Pregnancy
MSHAN-20230307-00591-ALT, March 7, 2023
-
Increased Chikungunya Virus Activity in Paraguay Associated with Travelers
CDCHAN-20230303-00487, March 3, 2023
-
Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears
CDCHAN00485, 02/02/2023
-
Updated Nursing Home Guidance for Candida auris
Update to MSHAN-20230111-00590-UPD, January 11, 2023
-
Mississippi Candida auris Update: January 11, 2023
MSHAN-20230111-00590-UPD, January 11, 2023
-
Ongoing Outbreak of Locally Acquired Candida auris Cases Identified in Mississippi
MSHAN-20221223-00589-ALT, December 23, 2022
-
Multistate Norovirus Outbreak Linked to Raw Oysters from Texas
MSHAN-20221221-00588-ALT, December 21, 2022
-
Ebola Virus Update: Central Uganda 2022
CDCHAN-20221107-00480-UPD, November 7, 2022
-
Monkeypox Update—Expanded Vaccine Eligibility
MSHAN-20221027-00587-UPD, October 27, 2022
-
Ebola Update and Virtual Town Hall -Preparing Frontline Healthcare Workers for Ebola on 10202022
MSHAN-20221018-00586-ADV, October 18, 2022
-
Ebola Virus Update – Uganda 2022
CDCHAN-20221011-00477-ADV, October 11, 2022
-
Melioidosis in the United States: What Clinicians Need to Know Following Newly Discovered Endemicity
MSHAN-20221006-00587-ADV, October 6, 2022
-
Severe Manifestations of Monkeypox among People who are Immunocompromised Due to HIV or Other Conditions
CDCHAN-20220930-00475, September 30, 2022
-
EMS Tiered Response
MSHAN-20220630-00577, June 30, 2022
-
Infant Formula Shortage and the Mississippi State Department of Health Response
MSHAN-20220601-00576-ALT, June 1, 2022
-
Suspect Monkeypox Virus Infection Testing
MSHAN-2020525-00575-ALT, May 25, 2022
-
COVID-19 Vaccine Booster Dose Recommended for Children 5-11 years of Age
MSHAN-2020524-00574-ALT, May 24, 2022
-
Monkeypox Virus Infection in the United States and Other Non-endemic Countries, 2022
MSHAN-2020520-00573-ADV, May 20, 2022
-
Updated Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
MSHAN-2020513-00572, May 13, 2022
-
CDC Health Advisory for updated information for the treatment of outpatients with mild to moderate COVID-19
MSHAN-20220426-00571-ALT, April 26, 2022
-
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
MSHAN-20220421-00570-ALT, April 21, 2022
-
Sotrovimab No Longer Authorized for the Treatment of COVID-19 Infection in the US
MSHAN-20220407-00568-ALT, April 7, 2022
-
Updated SARS-CoV-2 Reporting Requirements – Revised
MSHAN-20220407-00567-ALT, April 7, 2022
-
Updated SARS-CoV-2 Reporting Requirements
MSHAN-20220331-00566-ALT, March 31, 2022
-
STATE HEALTH OFFICERS ORDER: EMS Tiered Response
MSHAN-20220330-00565-ALT, March 30, 2022
-
Update: COVID-19 Vaccine Second Booster Dose Recommendations
MSHAN-20220330-00564-ALT, March 30, 2022
-
Adverse Events Associated with Tianeptine: an Unapproved Drug
MSHAN-20220324-00563-ALT, March 24, 2022
-
UPDATE: Bebtelovimab Monoclonal Antibody for the Treatment of Mild to Moderate COVID-19 Infection
MSHAN-20220303-00562-ALT, March 3, 2022
-
UPDATE: EVUSHELD for Pre-Exposure Prophylaxis of COVID-19 in Special Populations
MSHAN-20220225-00560-ALT, February 25, 2022
-
COVID-19 Therapeutics – UPDATES – Paxlovid and molnupiravir available at Kroger, Wal-Mart, and other community pharmacies
MSHAN-20220218-00559-ALT, February 18, 2022
-
Updated COVID-19 Vaccination Guidance for Immunocompromised Individuals or Individuals with Prior Receipt of Monoclonal Antibodies
MSHAN-20220217-00558-ALT, February 17, 2022
-
STATE HEALTH OFFICERS ORDER: EMS Tiered Response
MSHAN-20220204-00557-ALT, February 4, 2022
-
STATE HEALTH OFFICERS ORDER: ICU Rotation Extension 02.02.2022
MSHAN-20220202-00556-ALT, February 2, 2022
-
STATE HEALTH OFFICERS ORDER: ICU Rotation
MSHAN-20220130-00554-ALT, January 30, 2022
-
COVID-19 Therapeutics-UPDATES-Use of REGEN-COV and Bamlanivimab/Etesevimab No Longer Authorized by FDA; Remdesivir Approved for Outpatient Treatment
MSHAN-20220126-00553-ALT, date
-
STATE HEALTH OFFICERS ORDER: ICU Rotation Extension
MSHAN-20220122-00552-ALT, January 22, 2022
-
COVID-19 Therapeutics
MSHAN-20220121-00551-ALT, January 21, 2022
-
State Health Officer's Order: ICU Rotation
MSHAN-20220111-00550-ALT, January 11, 2022
-
State Health Officer Order: Nursing Home Staff Employee Vaccination Testing
MSHAN-20220105-00549-ALT, January 5, 2022
To view/print pdf documentation you will need Adobe Reader
Sign up for weekly public health updates by e-mail:
Mississippi State Department of Health • 570 East Woodrow Wilson Dr • Jackson, MS 39216 • 866-HLTHY4U • Contact and information
